Patent ID: 11879139
Assignee: PORTON ADVANCED SOLUTIONS LTD.
Field: Chemical engineering (Chemistry)
Classification: CPC C  B | IPC C

Claim 10:
11. The method of claim 10, wherein the therapeutic protein is selected from the group consisting of: chimeric antigen receptor (CAR), an enzyme, cytokine, chemokine, hormone, antibody, anti-oxidant molecule, engineered immunoglobulin-like molecule, single chain antibody, fusion protein, immune co-stimulatory molecule, immunomodulatory molecule, a transdomain negative mutant of a target protein, toxin, conditional toxin, antigen, transcription factor, structural protein, reporter protein, subcellular localization signal, tumor suppressor protein, growth factor, membrane protein, receptor, vasoactive protein or peptide, anti-viral protein or ribozyme, or a derivative thereof, or a micro-RNA.